Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016387007> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W2016387007 abstract "Bisphosphonates, potent anti-osteoclastic agents, are nowadays the first-line therapy for Paget's disease of bone. Solid evidence about efficacy and the risk/benefit ratio favor tiludronate and risedronate for oral administration and pamidronate for intravenous administration. Treatment is always intermittent, with the frequency of therapeutic sequences depending on the specific drug and the quality and duration of response. Treatment response is assessed by the extent of the reduction of biochemical markers of bone turnover, especially plasma total alkaline phosphatase. The goal of the treatment is to induce full remission, that is, normal levels of alkaline phosphatase. Bisphosphonates should be used in all patients with bone involvement that might create long-term articular (arthropathy) or neurologic (compression) complications. This aggressive strategy is the most likely to provide effective prevention of complications in the long term." @default.
- W2016387007 created "2016-06-24" @default.
- W2016387007 creator A5005235245 @default.
- W2016387007 creator A5044192767 @default.
- W2016387007 date "2005-04-01" @default.
- W2016387007 modified "2023-10-18" @default.
- W2016387007 title "Maladie de Paget, prise en charge thérapeutique" @default.
- W2016387007 cites W1964350922 @default.
- W2016387007 cites W1966022820 @default.
- W2016387007 cites W1978701783 @default.
- W2016387007 cites W1987690548 @default.
- W2016387007 cites W2001229600 @default.
- W2016387007 cites W2011959757 @default.
- W2016387007 cites W2026256336 @default.
- W2016387007 cites W2029384287 @default.
- W2016387007 cites W2044519389 @default.
- W2016387007 cites W2045747724 @default.
- W2016387007 cites W2055036552 @default.
- W2016387007 cites W2061536449 @default.
- W2016387007 cites W2070954925 @default.
- W2016387007 cites W2073695084 @default.
- W2016387007 cites W2078468996 @default.
- W2016387007 cites W2125212648 @default.
- W2016387007 cites W2136023404 @default.
- W2016387007 cites W2142734448 @default.
- W2016387007 cites W2146860527 @default.
- W2016387007 cites W2326201416 @default.
- W2016387007 cites W2414407528 @default.
- W2016387007 cites W584104604 @default.
- W2016387007 cites W2411682710 @default.
- W2016387007 cites W2481156655 @default.
- W2016387007 doi "https://doi.org/10.1016/s0755-4982(05)83991-0" @default.
- W2016387007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15962504" @default.
- W2016387007 hasPublicationYear "2005" @default.
- W2016387007 type Work @default.
- W2016387007 sameAs 2016387007 @default.
- W2016387007 citedByCount "0" @default.
- W2016387007 crossrefType "journal-article" @default.
- W2016387007 hasAuthorship W2016387007A5005235245 @default.
- W2016387007 hasAuthorship W2016387007A5044192767 @default.
- W2016387007 hasConcept C29456083 @default.
- W2016387007 hasConcept C71924100 @default.
- W2016387007 hasConceptScore W2016387007C29456083 @default.
- W2016387007 hasConceptScore W2016387007C71924100 @default.
- W2016387007 hasLocation W20163870071 @default.
- W2016387007 hasLocation W20163870072 @default.
- W2016387007 hasOpenAccess W2016387007 @default.
- W2016387007 hasPrimaryLocation W20163870071 @default.
- W2016387007 hasRelatedWork W1987767691 @default.
- W2016387007 hasRelatedWork W2021490637 @default.
- W2016387007 hasRelatedWork W2045220618 @default.
- W2016387007 hasRelatedWork W2065976886 @default.
- W2016387007 hasRelatedWork W2080270454 @default.
- W2016387007 hasRelatedWork W2151253362 @default.
- W2016387007 hasRelatedWork W2155991793 @default.
- W2016387007 hasRelatedWork W2315643016 @default.
- W2016387007 hasRelatedWork W2414643024 @default.
- W2016387007 hasRelatedWork W2734470248 @default.
- W2016387007 isParatext "false" @default.
- W2016387007 isRetracted "false" @default.
- W2016387007 magId "2016387007" @default.
- W2016387007 workType "article" @default.